Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Presented for research literature review only Boyle C et al
Patients with severe gastroparesis may experience altered drug absorption and increased side effects, potentially affecting the speed of therapeutic response
Lilly's triple agonist retatrutide posted 28.7% weight loss in TRIUMPH-4 Phase 3, the highest figure from any GLP-1-class drug to date
A study of 168 pregnancies with first-trimester exposure to GLP-1s did not show increased chance of miscarriage, preterm delivery, stillbirth, or SGA infants (small for gestational age-infants whose birth weight is below the 10 th percentile for their gestation age)
US$ 22.90
US$ 24.05
US$ 23.20
US$ 25.63
US$ 25.75
US$ 22.53
US$ 23.48
US$ 27.73
US$ 22.67
US$ 28.57
